CancerIQ, a provider of precision health platform for cancer risk assessment to hospitals, raised $4.8 million in Series A. Health-focused venture capital firm HealthX Ventures

CancerIQ, a provider of precision health platform for cancer risk assessment to hospitals, raised $4.8 million in Series A. Health-focused venture capital firm HealthX Ventures
Eden Health, a direct-to-employer telehealth platform, raised $25 million in Series B funding. The company partners with employers to offer telehealth services to their employees.
Cecelia Health, a provider of telehealth services for diabetes and other chronic diseases, completed a $13 million Series B funding round. Rittenhouse Ventures and Endo
Lumeon, a digital health company specializing in care pathway orchestration, closed a $30 million Series D funding round. The funding was led by new investors
Nurx, a telemedicine platform that offers birth control prescriptions, raised an additional $22.5 million in Series C funding, bringing its C round to $74.5 million.
Voiceitt, a speech recognition software for people with speech and motor disabilities, raised an additional $10 million in a Series-A funding round. According to the
Sift Healthcare, a medical billing analytics and data science platform powered by artificial intelligence, closed a $2.8 million new funding round. The funding round was
Xealth – a digital prescribing platform that enables physicians and clinicians to prescribe customized digital healthcare content such as exercise programs, educational videos, apps, and
Ginger, a provider of mental health telemedicine services through its app, raises $50 million in Series D funding round. The round was led by Advance
AI-enabled symptom checker Infermedica has raised $10.25 million in Series A funding. Infermedica says the new funds will be used for research and development to